Selected transactions
Deal Type
Share Capital Increase via preferred Convertible Offering to a consortium of new investors to support international deployment.
Exclusive Financial Advisor to ERC for a share capital increase subscribed by UHNWI investors.
Exclusive advisor, listing Sponsor and Sole Bookrunner for Novagali’s Initial Public Offering.
Exclusive Financial Advisor in the third-tranche of follow-on offerings corresponding to a capital increase with subscription rights for Transgene.
Exclusive Advisor, Listing Sponsor and Sole Bookrunner for cancer diagnostic specialist Ipsogen.
Exclusive financial advisor to Teva in the issuance of a convertible bond offering.
Exclusive Financial Advisor for the issuance of equity instruments (SWORD: Stock Warrant Off-Balance-Sheet R&D vehicle), consisting in the demerger of Central Nervous System assets.